ChinaBio Partnering Forum EBD GroupChinaBIO
Share:
Email this page Share this on LinkedIn Share this on Twitter

ChinaBio® Partnering Forum 2014 Press Releases

April 3, 2014Involvement of international pharmaceutical companies in ChinaBio® Partnering Forum 2014 echoes compelling China market demand The 2014 edition of ChinaBio® Partnering Forum, China's only life science partnering event, is just weeks away, to be held May 7–8 at the Kempinski Hotel in Suzhou. Pharma companies strongly support the event, as many international companies seek to access the massive healthcare market and partnership opportunities for growth in China. AstraZeneca, Bayer, Bristol-Myers S...  more ►

April 2, 2014Spotlight on Suzhou Business Facts BioBay innovation cluster BioBay, located in the Dushu Lake Science and Education Innovation District in Suzhou, is an innovative science and technology carrier for development of the emerging biological industry, among other initiatives. Currently there are over 400 biotech companies in BioBay. Suzhou Industrial Park The Suzhou Industrial Park (SIP) is the largest in China, a...  more ►

February 5, 2014China's largest life science partnering event returns to Suzhou, ChinaChinaBio® Partnering Forum 2014 to draw pharma and biotech dealmakers
The 2014 edition of ChinaBio® Partnering Forum, China's premier life science partnering event, will be held May 7–8 at the Kempinski Hotel in Suzhou. In 2013, the Forum was attended by more than 750 delegates from 405 companies and 22 countries, making it the largest partnering conference in China. Pharma and biotech companies as well as leading researchers from China's ...  more ►



partnering360:Insight Latest headlines from partnering360:Insight

24 March 2014 China partnering grows The Year of the Horse recently began in China, symbolizing dramatic actions, a desire for success and a desire for freedom. Those desires are evidenced in the nation’s choice of reformers as leaders, and in its continued commitment to build an invigorating life sciences community. Last year, 2013, was the prelude. As Greg Scott, President, ChinaBio®, pointed out,“We saw a doubling of partnering deals in 2013, measured by value. The USD 560 million raised through 100 deals in 2012 climbed to USD 1.2 billion and 135 deals in 2013.” That may be just the tip of the proverbial iceberg, as values aren’t announced for every deal. more ►

24 March 2014 BioBay fosters innovation for itself and others Synergy is a theme within BioBay life sciences park. BioBay includes multiple life science disciplines and is designed to promote the natural cross-fertilization of ideas through conversations over coffee as well as through structured meetings and conferences and other interactions. more ►

24 March 2014 Qiming Ventures focuses on China Qiming Ventures is one of the largest and most active healthcare investors in China. Focusing exclusively on China since its founding in 2006, Qiming has invested in more than 90 companies, including 30 life sciences companies developing pharmaceuticals, tools or medical devices. more ►

16 March 2014 Getting to “yes” with effective due diligence There is a soft side of partnering where opportunities are discovered through networking, handshakes and trading information. Eventually there comes the hard part, due diligence where potential partners assess and validate claims and representations. At BIO-Europe Spring® in Turin, a panel of business development executives hardened by negotiations shared their experiences for ensuring a successful due diligence process. more ►

13 March 2014 Big biotechs seek growth in innovative deals with small biotechs "When I look at large pharma, I see zero creativity in the way they go about a deal," said John McDonald of Biogen on the opening plenary panel at BIO-Europe Spring® 2014 in Turin, Italy. more ►



Arrow Up


 
 
See more upcoming conferences ►

EBD Group's Family of Events

© 2009–2014 EBD Group, Inc.
Privacy Policy
Terms of Use
ChinaBio Partnering Forum EBD GroupChinaBIO